Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C COHN

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
MMWR. Morbidity and Mortality Weekly Report|June 18, 2025
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Agam K Rao, Faisal S Minhaj, Rosalind J Carter, et al.
MMWR. Morbidity and Mortality Weekly Report|October 6, 2022
Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022Amanda B Payne, Logan C Ray, Kiersten J Kugeler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2009
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal diseaseAmanda C Cohn, Jessica R MacNeil, Lee H Harrison, et al.
The New England Journal of Medicine|February 28, 2009
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North AmericaHenry M Wu, Brian H Harcourt, Cynthia P Hatcher, et al.
Pediatrics|April 29, 2015
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University OutbreakLucy A McNamara, Alice M Shumate, Peter Johnsen, et al.
Ophthalmology. Retina|October 5, 2019
Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study ReportZhichao Wu, Chi D Luu, Lauren A B Hodgson, et al.
Clinical & Experimental Ophthalmology|September 9, 2025
Deep Learning-Based Detection of Reticular Pseudodrusen in Age-Related Macular DegenerationHimeesh Kumar, Yelena Bagdasarova, Scott Song, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Deep Learning-Based Detection of Reticular Pseudodrusen in Age-Related Macular Degeneration on Optical Coherence TomographyHimeesh Kumar, Yelena Bagdasarova, Scott Song, et al.
The British Journal of Ophthalmology|May 4, 2026
Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi studyRoshan Karri, David C Sousa, Xavier Hadoux, et al.
MMWR. Morbidity and Mortality Weekly Report|May 18, 2023
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023Alexandra F Dalton, Alpha Oumar Diallo, Anna N Chard, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
MMWR. Morbidity and Mortality Weekly Report|June 18, 2025
Use of JYNNEOS (Smallpox and Mpox Vaccine, Live, Nonreplicating) for Persons Aged ≥18 Years at Risk for Mpox During an Mpox Outbreak: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023Agam K Rao, Faisal S Minhaj, Rosalind J Carter, et al.
MMWR. Morbidity and Mortality Weekly Report|October 6, 2022
Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022Amanda B Payne, Logan C Ray, Kiersten J Kugeler, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2009
Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal diseaseAmanda C Cohn, Jessica R MacNeil, Lee H Harrison, et al.
The New England Journal of Medicine|February 28, 2009
Emergence of ciprofloxacin-resistant Neisseria meningitidis in North AmericaHenry M Wu, Brian H Harcourt, Cynthia P Hatcher, et al.
Pediatrics|April 29, 2015
First Use of a Serogroup B Meningococcal Vaccine in the US in Response to a University OutbreakLucy A McNamara, Alice M Shumate, Peter Johnsen, et al.
Ophthalmology. Retina|October 5, 2019
Secondary and Exploratory Outcomes of the Subthreshold Nanosecond Laser Intervention Randomized Trial in Age-Related Macular Degeneration: A LEAD Study ReportZhichao Wu, Chi D Luu, Lauren A B Hodgson, et al.
Clinical & Experimental Ophthalmology|September 9, 2025
Deep Learning-Based Detection of Reticular Pseudodrusen in Age-Related Macular DegenerationHimeesh Kumar, Yelena Bagdasarova, Scott Song, et al.
Medrxiv : the Preprint Server for Health Sciences|September 24, 2024
Deep Learning-Based Detection of Reticular Pseudodrusen in Age-Related Macular Degeneration on Optical Coherence TomographyHimeesh Kumar, Yelena Bagdasarova, Scott Song, et al.
The British Journal of Ophthalmology|May 4, 2026
Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi studyRoshan Karri, David C Sousa, Xavier Hadoux, et al.
MMWR. Morbidity and Mortality Weekly Report|May 18, 2023
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023Alexandra F Dalton, Alpha Oumar Diallo, Anna N Chard, et al.
Pageof 11